Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Activating NRF1-BRAF and ATG7-RAF1 fusions in anaplastic pleomorphic xanthoastrocytoma without BRAF p.V600E mutation.

Acta neuropathologica - 1 Nov 2016

Phillips Joanna J, Gong Henry, Chen Katharine, Joseph Nancy M, van Ziffle Jessica, Jin Lee-Way, Bastian Boris C, Bollen Andrew W, Perry Arie, Nicolaides Theodore, Solomon David A, Shieh Joseph T

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Brain Neoplasms
Share to DNA Helicases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glutamic Acid

Share to Mitogen-Activated Protein Kinase Kinases

Share to raf Kinases

Share to Valine

Share to World Health Organization

Source

Open in PubMed Open full text

Identifiers

PMID: 27624885
DOI: 10.1007/s00401-016-1616-3
PMCID: PMC5074852

Genes

BRAF
ATG7
NRF1
RAF1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Activating NRF1-BRAF and ATG7-RAF1 fusions in anaplastic pleomorphic xanthoastrocytoma without BRAF p.V600E mutation.PMID 27624885Read ↗

BRAF V600E mutation: A treatable driver mutation in pleomorphic xanthoastrocytoma (PXA).Semantic proximity Read ↗

A novel, potentially targetable TMEM106B-BRAF fusion in pleomorphic xanthoastrocytoma.Semantic proximity Read ↗

Changes in cell morphology and function induced by the NRAS Q61R mutation in lymphatic endothelial cells.Semantic proximity Read ↗

Molecular features of pleomorphic xanthoastrocytomaSemantic proximity Read ↗

Identification of BRAF p. V600E-Mutant and Wild-Type by MR Imaging in Pleomorphic Xanthoastrocytoma and Anaplastic Pleomorphic Xanthoastrocytoma.Semantic proximity Read ↗

Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up.Semantic proximity Read ↗

Pleomorphic xanthoastrocytoma, anaplastic pleomorphic xanthoastrocytoma, and epithelioid glioblastoma: Case series with clinical characteristics, molecular features and progression relationship.Semantic proximity Read ↗

BRAF/MEK Dual Inhibitors Therapy in Progressive and Anaplastic Pleomorphic Xanthoastrocytoma: Case Series and Literature Review.Semantic proximity Read ↗

A Rare Case of BRAF-mutated Metastatic Pleomorphic Xanthoastrocytoma Patient who Developed Radiodermatitis After Receiving Anti-BRAF Treatment.Semantic proximity Read ↗

BRAF activating mutations involving the β3-αC loop in V600E-negative anaplastic pleomorphic xanthoastrocytoma.Semantic proximity Read ↗

Rare AGK-BRAF gene fusion in an adolescent with supratentorial pleomorphic xanthoastrocytoma.Semantic proximity Read ↗

Successful Treatment of a Progressive BRAF V600E-Mutated Anaplastic Pleomorphic Xanthoastrocytoma With Vemurafenib Monotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.